Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
about
Small intestinal bacterial overgrowth in patients with irritable bowel syndromeSystematic review: the use of proton pump inhibitors and increased susceptibility to enteric infectionUpper gastrointestinal microbiota and digestive diseasesDo we need gastric acid?Effects of long-term PPI treatment on producing bowel symptoms and SIBO.Diagnosis and management of small intestinal bacterial overgrowth.Gas and Bloating.Personal review: is profound acid inhibition safe?Effect of gastric acid suppressants and prokinetics on peritoneal dialysis-related peritonitis.Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.Hydrogen and methane gases are frequently detected in the stomachAdverse effects of long-term proton pump inhibitor therapy.Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study.Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.Prevention of parenteral nutrition-associated liver disease in children.The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither?Acetaldehyde, microbes, and cancer of the digestive tract.Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections.Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control studyAn Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression.Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.Extensive atrophic gastritis increases intraduodenal hydrogen gas.Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.The importance of the gut microbiota after bariatric surgery.Indications and safety of proton pump inhibitor drug use in patients with cancer.Prostaglandin pathways in duodenal chemosensingProton pump inhibitors and the risk of colorectal cancer.Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy.Enteral nutrition and the small intestine.Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.Hunger and microbiology: is a low gastric acid-induced bacterial overgrowth in the small intestine a contributor to malnutrition in developing countries?Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.Radiation lethality potentiation in total body irradiated mice by a commonly prescribed proton pump inhibitor, Pantoprazole sodium.Omeprazole induces altered bile acid metabolism.
P2860
Q24674609-E8C38994-6D28-46EA-8397-EE111C3B8734Q26849521-32502772-136F-407E-B7E3-4AB3DDDCFC04Q27002380-F362FA50-B434-456B-8015-3216F505700AQ33348215-D11A6376-D554-4641-BC85-EC0B1FE1B055Q33448825-2B31002E-F248-49D8-A338-A1B454C9B7CBQ33457767-EE230427-6143-47D4-8DC9-5770F3BD080CQ33470091-5759480F-2A3A-44F7-B776-6D8835726F84Q33815745-6983800F-159D-492F-9A2A-15AE124D4352Q33845539-1898D071-7A28-4614-9A34-5BEA048A5AFEQ33940198-89892184-FFB5-4056-8B36-C1CA381C42D2Q34012973-6FB2A8E1-48B6-441D-BCD3-0E65EF6B2D01Q34167899-D2FB0D69-4657-4FD2-8FEA-4194AFE01F37Q34170707-405BA4D5-A1C5-45EF-824B-2D343E405255Q34403939-385388D9-2A0A-4FEF-90DD-84B3878ECF9EQ34409933-1242529F-1AC8-44D9-B3A9-2A2F9E1545F5Q34572743-2D5EFE8A-ECA3-4A81-9D5E-8DD29A9BEBE7Q34985967-9E84789F-CEEC-4D0C-ABD2-C6FADC24940EQ35130665-27D63DF7-486D-4C76-9FA0-B50E4C483572Q35194532-EC06D1A1-3796-4DA1-8091-5754D323405BQ35653793-8B635C2E-23B3-483A-926E-031657CF8549Q35917169-36DC8FDF-30B0-4DD8-A776-085B269DC265Q36193661-2D4C92B2-C359-4976-876B-0C503ACBCCA8Q36293975-EEB599C7-D94A-49CD-BFB4-3C2EF4C2E02AQ36873997-B6E56571-7BEF-4641-AE54-838C4F6538C2Q36942298-D679D795-A239-4F14-B1A4-CF9A129B4F43Q37852084-EB83DE99-B593-4B4F-B634-0012B2D4F7CEQ37983998-36576190-89AB-4C79-8CA9-76940F6D548DQ38038435-91389BAC-7871-4340-B552-8641BE9C7A04Q38104388-41ADBC1D-BE10-4A36-86FE-F422D3278997Q38293032-92344E7D-E155-40CE-8C56-D5E2CE45AEA1Q38459132-0D2630E1-40B4-4178-98E0-7378FF08A179Q38645247-2FDC287C-F155-4768-85AB-F81BF933DB72Q38865456-69848634-7EFC-4CC0-A05D-A7D2FB3C3A99Q39851554-EC180CB6-B44E-4322-899E-F99420419D18Q40575407-E14720D3-0F81-49DE-A4BD-B1EE55F11D4EQ41076222-1F09452F-B66D-4DF7-BD57-CEE514A483A6Q41693380-37410CC9-0446-4690-9457-762B796942B9Q41919143-17629247-75E8-4F4F-A8E0-14201890D839Q41963458-041FED8E-5579-485E-807B-42D3CDB14F07Q42038731-45EEF068-C562-4CF7-BFFD-69025935D95C
P2860
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@ast
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@en
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@nl
type
label
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@ast
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@en
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@nl
prefLabel
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@ast
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@en
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@nl
P2093
P2860
P356
P1433
P1476
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole
@en
P2093
Froehlich F
Gonvers JJ
Siegrist H
P2860
P356
10.1136/GUT.35.1.23
P407
P577
1994-01-01T00:00:00Z